Boston, Massachusetts, United States The venture was found in North America in United States. The main office of represented VC is situated in the Boston.
Among the various public portfolio startups of the fund, we may underline Intrapace, Healthcare Management Directions, Pathogenetix The fund has exact preference in some founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular fund investment industries, there are Genetics, Biopharma. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the CB Health Ventures, startups are often financed by Flagship Pioneering, Alta Partners, Sherbrooke Capital. The meaningful sponsors for the fund in investment in the same round are Flagship Pioneering, Zero Stage Capital, Sherbrooke Capital. In the next rounds fund is usually obtained by 3i Group, Flagship Pioneering, VantagePoint Capital Partners.
The typical startup value when the investment from CB Health Ventures is 10-50 millions dollars. The real fund results show that this VC is 15 percentage points less often commits exit comparing to other companies. The higher amount of exits for fund were in 2019. The fund is generally included in less than 2 deals every year. Deals in the range of 10 - 50 millions dollars are the general things for fund. Comparing to the other companies, this CB Health Ventures performs on 3 percentage points more the average number of lead investments. The top activity for fund was in 2004.
The current fund was established by Robert Schulz.
Related Funds
Funds with similar focus
| Fund Name | Location |
| AmTRAN Technology | Taipei, Taiwan |
| Biosys Capital | - |
| China Health Industry Investment Fund | - |
| CMU OFEF | Pennsylvania, Pittsburgh, United States |
| CNO Financial Group | Carmel, Indiana, United States |
| D2C Inc. | - |
| Encovox | - |
| Financial Information Technologies (Fintech) | Florida, Tampa, United States |
| GE | Atlanta, Georgia, United States |
| Global Asia Partners | Central, Central Region, Singapore |
| HMA Capital Partners | Lansing, Michigan, United States |
| Partners Financial Services | Czech Republic, Prague, Prague |
| Shanghai Huarui Bank | China, Shanghai |
| Shenzhenshi Yunhang Keji Youxian Gongsi | China, Guangdong, Shenzhen |
| Siemer & Associates | California, Santa Monica, United States |
| Socogame | China, Shanghai |
| Sumitomo Mitsui Banking Corporation | Chiyoda, Japan |
| Wesfarmers | Australia, Perth, Western Australia |
| Windrose Capital | India, Maharashtra, Pune |
| Yingzhi (Yinchuan) Touzi Guanli Co., Ltd. | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Openwater | 01 Mar 2018 | San Francisco, California, United States | |||
Pathogenetix | $7M | 01 Nov 2011 | Woburn, Massachusetts, United States | ||
Pathogenetix | $4M | 01 Aug 2011 | Woburn, Massachusetts, United States | ||
Activate Networks | $5M | 09 Aug 2010 | Newton, Massachusetts, United States | ||
Pathogenetix | $4M | 14 Jul 2008 | Woburn, Massachusetts, United States | ||
Aileron Therapeutics | $7M | 01 Dec 2006 | Cambridge, Massachusetts, United States | ||
TransMedics | $29M | 14 Mar 2006 | Massachusetts, United States | ||
Carefx | $12M | 25 Oct 2005 | Scottsdale, Arizona, United States | ||
Carefx | 22 Sep 2005 | Scottsdale, Arizona, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Openwater | 01 Mar 2018 | San Francisco, California, United States | |||
Pathogenetix | $7M | 01 Nov 2011 | Woburn, Massachusetts, United States | ||
Pathogenetix | $4M | 01 Aug 2011 | Woburn, Massachusetts, United States | ||
Activate Networks | $5M | 09 Aug 2010 | Newton, Massachusetts, United States | ||
Pathogenetix | $4M | 14 Jul 2008 | Woburn, Massachusetts, United States | ||
Aileron Therapeutics | $7M | 01 Dec 2006 | Cambridge, Massachusetts, United States | ||
TransMedics | $29M | 14 Mar 2006 | Massachusetts, United States | ||
Carefx | $12M | 25 Oct 2005 | Scottsdale, Arizona, United States | ||
Carefx | 22 Sep 2005 | Scottsdale, Arizona, United States |
